ArticleFrontiers in endocrinology2026
Association between ovarian sensitivity index and IVF-ET outcomes in women of advanced maternal age.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the association between the ovarian sensitivity index (OSI) and ovarian responsiveness, embryo quality, and pregnancy outcomes in women of advanced reproductive age (≥35 years) undergoing IVF-ET. Methods: This retrospective cohort study included 1,055 fresh embryo transfer cycles performed at the Reproductive Medicine Center of Yulin Maternal and Child Health Hospital between January 1, 2021, and December 31, 2023. Patients were stratified by OSI tertiles: low (≤2.174, n=353), middle (2.174- 4.103, n=351), and high (>4.103, n=351). Multivariable logistic regression was used to adjust for confounders and assess the independent association between OSI and clinical pregnancy. Results: No significant differences were observed in infertility duration, BMI, LH, E2, T, P, or endometrial thickness on HCG day (all P>0.05). The high OSI group was younger with lower FSH and higher AMH/AFC (P<0.05), required less Gn and shorter stimulation, and yielded more oocytes, 2PN embryos, available embryos, and high-quality Day 3 embryos (P<0.05). Implantation and clinical pregnancy rates were higher in the high OSI group (P<0.05), but no differences were seen in live birth, multiple pregnancy, or early miscarriage rates (all P>0.05). Of note, the live birth rate - the most clinically meaningful endpoint in IVF - did not differ significantly across OSI tertiles (P = 0.412), indicating that the higher clinical pregnancy rates in the high OSI group did not translate into a higher live birth rate. After adjustment for age, FSH, AMH, and AFC, OSI tertiles were not independently associated with clinical pregnancy (overall P = 0.357). Age (OR = 0.880, 95% CI: 0.833-0.930, P<0.001) and AMH (OR = 1.114, 95% CI: 1.002-1.238, P = 0.046) remained independent predictors. Conclusion: In univariate analysis, higher OSI was associated with ovarian responsiveness, embryo quality, and clinical pregnancy rates; however, it is not independently associated with clinical pregnancy after adjustment for confounding factors, particularly age and AMH. OSI may serve as a composite indicator reflecting ovarian responsiveness and embryo quality, but should be interpreted in conjunction with age, AMH, and other relevant clinical factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.